Abstracts Archive - Page 376 of 1683 - ATC Abstracts

2020 American Transplant Congress
Effects of Donor Heavy Alcohol Use on Post-Heart Transplant Outcomes: Time to Abstain?
J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, G. Jamero, L. Czer, F. Esmailian, J. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Donors with a history of heavy alcohol use have been suspected to possibly harbor a subclinical alcoholic cardiomyopathy with limited cardiac reserve. This problem…
2020 American Transplant Congress
The Frequency of De Novo DSA in the Years Following Heart Transplantation
A. Shen, J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, K. Nishihara, L. Czer, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: The timing of the development of donor specific antibody (DSA) after heart transplantation is not clear. De novo DSA has been reported to be…
2020 American Transplant Congress
Post Heart Transplant Outcomes for Patients with Cardiac Sarcoidosis
G. S. Liu¹, E. C. DePasquale¹, A. M. Wolfson², R. R. Chand³, P. Banankhah¹, J. Nattiv¹, A. D. Salimbangon⁴, P. A. Genyk¹, P. A. Kingsford¹, J. P. Li¹, D. Vucicevic⁵, K. Pandya¹, J. Rahman¹, M. Fong¹, A. S. Vaidya¹
¹Keck Medicine of USC, Los Angeles, CA, ²University of Arizona Sarver Heart Center, Tucson, AZ, ³Harbor-UCLA Medical Center, Los Angeles, CA, ⁴UCLA Medical Center, Los Angeles, CA, ⁵Newark Beth Israel Medical Center, Newark, NJ
*Purpose: Cardiac sarcoidosis (CS) is a known etiology of end-stage dilated, hypertrophic, or arrhythmogenic cardiomyopathies requiring heart transplantation (HT). We sought to evaluate the long-term…
2020 American Transplant Congress
A Quality Improvement Project to Reduce the Risk of Alcohol Relapse after Liver Transplantation by Implementing a High-Risk Alcoholism Relapse Scale
R. V. Tholen¹, E. Bundy²
¹Transplant Nephrology, University of Maryland Medical Center, Baltimore, MD, ²School of Nursing, University of Maryland, Baltimore, Baltimore, MD
*Purpose: Alcoholism is the leading cause of liver-related mortality worldwide. Liver transplantation is considered the only curative treatment for end-stage liver disease. Transplantation will reverse…
2020 American Transplant Congress
Alterations in Left Ventricular Wall Thickness after Cardiac Transplantation
C. K. Alvarez, O. Saeed, S. R. Patel, E. Borukhov, U. Jorde
Advanced Heart Failure, Transplant and Mechanical Circulatory Support, Montefiore Medical Center, Albert Einstein, Bronx, NY
*Purpose: We investigated changes in cardiac wall thickness of donor hearts over time, including the peri-operative OHT period (within 4 days after transplantation) and up…
2020 American Transplant Congress
The Association between Preoperative Hemodynamics and Right Ventricular Failure Following Implantation of Left Ventricular Assist Device
D. Bhakta¹, A. Alam², J. S. van Zyl², H. Zafar², A. Aasim², D. M. Meyer², J. Felius², S. Hall², D. Wencker²
¹Texas A&M University College of Medicine, Dallas, TX, ²Baylor University Medical Center, Dallas, TX
*Purpose: Right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation is a common complication and associated with increased mortality. Clinical predictors contributing to…
2020 American Transplant Congress
Recruitment in the Pediatric Heart Transplant TEAMMATE Trial: Observed vs. Expected
K. P. Daly, L. A. Sleeper, L. J. Addonizio, J. C. Alejos, S. Auerbach, M. J. Bock, A. Butto, W. F. Carlo, C. Castleberry, W. J. Dreyer, B. Feingold, J. M. Lamour, E. L. Albers, S. A. Hollander, G. L. Klein, A. Lal, E. Pahl, D. Peng, A. R. Punnoose, J. W. Rossano, T. D. Ryan, J. Su, D. L. Sutcliffe, S. Zangwill, C. S. Almond
TEAMMATE Trial Investigators, Boston, MA
*Purpose: The TEAMMATE (Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients using the MATE Score) Trial is the first multicenter effort to address key scientific…
2020 American Transplant Congress
Resilience in Heart Transplant Candidates
Y. T. Bui¹, D. S. Yip², B. W. Hardaway³, S. M. Dunlay⁴, S. Jowsey-Gregoire⁵, R. Benzo⁶, R. C. Daly⁷, M. A. Hathcock⁸, K. Thompson⁹, C. C. Kennedy¹⁰
¹Mayo Clinic Alix School of Medicine, Rochester, MN, ²Department of Transplantation, Mayo Clinic, Jacksonville, FL, ³Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, ⁴Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, ⁵Department of Psychiatry, Mayo Clinic, Rochester, MN, ⁶Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, ⁷Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, ⁸Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, ⁹Pulmonary Clinical Research Unit, Mayo Clinic, Rochester, MN, ¹⁰William J. von Liebig Center for Transplantation and Regenerative Medicine, Mayo Clinic, Rochester, MN
*Purpose: Resilience is the capacity to adapt to or recover from adverse experiences. Our objective was to measure resilience in waitlisted, adult heart transplant candidates…
2020 American Transplant Congress
Evaluation of SUBA-Itraconazole Use in Lung Transplant Recipients
J. G. Youssef¹, C. Ahmed¹, B. J. Pierce², C. Pham², F. Ye¹, K. Tatum¹, S. Yau¹, A. Goodarzi¹, H. J. Huang¹
¹Department of Medicine, Houston Methodist Hospital, Houston, TX, ²Department of Pharmacy, Houston Methodist Hospital, Houston, TX
*Purpose: Itraconazole (IT) is commonly used after lung transplant for fungal prophylaxis, particularly in those with a history of skin cancer, concern for Histoplasmosis infection,…
2020 American Transplant Congress
Bariatric Surgery for Congestive Heart Failure Patients Improves Access to Transplantation and Long-Term Survival
R. A. Choudhury¹, G. Hoeltzel², H. B. Moore¹, H. Yaffe¹, D. Yoeli¹, K. R. Dumon³, K. D. Conzen¹, T. L. Nydam¹
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²Thomas Jefferson University Hospital, Philadelphia, PA, ³Department of Surgery, University of Colorado Hospital, Philadelphia, PA
*Purpose: Obese patients with congestive heart failure (CHF) are often denied access to heart transplantation until they obtain significant weight loss to achieve a certain…